A Phase 2 clinical trial involving oxytocin was updated on August 21, 2026. The study, titled "Oxytocin Pharmacokinetics and Pharmacodynamics," is registered under identifier NCT05488457. According to the ClinicalTrials.gov record, the trial's current status is listed as recruiting. The trial is designated as Phase 2 in the registry. No results have been posted for this study as of the update date. The registry entry does not provide additional detail beyond the trial title, phase, and recruiting status. Oxytocin is an approved compound, and this trial update reflects an active research effort examining its pharmacokinetic and pharmacodynamic properties. Readers interested in the study can consult the ClinicalTrials.gov listing directly for enrollment criteria and further trial details. For more background on oxytocin as a compound, see the linked overview.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT05488457"]